These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21391893)

  • 1. Harm reduction and 12 steps: complementary, oppositional, or something in-between?
    Lee HS; Engstrom M; Petersen SR
    Subst Use Misuse; 2011; 46(9):1151-61. PubMed ID: 21391893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advocacy for harm reduction in China: a new era dawns.
    Reid G; Aitken C
    Int J Drug Policy; 2009 Jul; 20(4):365-70. PubMed ID: 19097773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.
    Avants SK; Margolin A; Usubiaga MH; Doebrick C
    J Subst Abuse Treat; 2004 Mar; 26(2):67-78. PubMed ID: 15050083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New York harm reduction educators.
    Ruefli T
    Newsline People AIDS Coalit N Y; 1998 Jun; ():9-12. PubMed ID: 11367473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Harm Reduction Coalition.
    Clear A; Springer E; Lanier C
    Newsline People AIDS Coalit N Y; 1998 Jun; ():27-34. PubMed ID: 11367469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of community-based nurses in harm reduction for HIV prevention: a South East and South Asia case study.
    Limbu B
    Int J Drug Policy; 2008 Jun; 19(3):211-3. PubMed ID: 18440796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Young people and drugs: next generation of harm reduction.
    Merkinaite S; Grund JP; Frimpong A
    Int J Drug Policy; 2010 Mar; 21(2):112-4. PubMed ID: 20036526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.
    Hammett TM; Wu Z; Duc TT; Stephens D; Sullivan S; Liu W; Chen Y; Ngu D; Des Jarlais DC
    Addiction; 2008 Jan; 103(1):137-45. PubMed ID: 18028519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principles of harm reduction. Harm Reduction Coalition.
    Newsline People AIDS Coalit N Y; 1998 Jun; ():7-8. PubMed ID: 11367472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
    Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
    Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the role of harm reduction when drug users say they want abstinence?
    Neale J; Nettleton S; Pickering L
    Int J Drug Policy; 2011 May; 22(3):189-93. PubMed ID: 21055914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Merseyside, the first harm reduction conferences, and the early history of harm reduction.
    O'Hare P
    Int J Drug Policy; 2007 Mar; 18(2):141-4. PubMed ID: 17689357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Legal harm reduction among intravenous drug users.
    Kongsakon R; Pocham N
    J Med Assoc Thai; 2006 Sep; 89(9):1545-50. PubMed ID: 17100399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower injection-related HIV-1 risk associated with participation in a harm reduction program in Kazan, Russia.
    Badrieva L; Karchevsky E; Irwin KS; Heimer R
    AIDS Educ Prev; 2007 Feb; 19(1):13-23. PubMed ID: 17411386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the reach of harm reduction in Thailand: experiences with a drug user-run drop-in centre.
    Kerr T; Hayashi K; Fairbairn N; Kaplan K; Suwannawong P; Zhang R; Wood E
    Int J Drug Policy; 2010 May; 21(3):255-8. PubMed ID: 19766474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug substitution therapy: a new approach in preventing the spread of HIV/AIDS in Malaysia.
    Razali SM
    Trop Doct; 2008 Apr; 38(2):109-10. PubMed ID: 18453507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Harm reduction--on the paradigm changes in drug dependence treatment].
    Kuhlmann T
    Psychiatr Prax; 1996 Jul; 23(4):157-60. PubMed ID: 8927642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
    Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
    Emmanuel F; Fatima M
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing prevalence of HIV, and persistent high-risk behaviours among drug users in Bangladesh: need for a comprehensive harm reduction programme.
    Islam MM; Conigrave KM
    Drug Alcohol Rev; 2007 Jul; 26(4):445-54. PubMed ID: 17564883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.